| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.32B | 47.96B | 45.22B | 43.42B | 43.34B | 51.33B |
| Gross Profit | 16.91B | 16.52B | 16.36B | 16.42B | 16.66B | 24.37B |
| EBITDA | 4.41B | 3.60B | 3.71B | 4.24B | 4.84B | 4.69B |
| Net Income | 1.72B | 1.40B | 1.80B | 2.18B | 2.70B | 2.51B |
Balance Sheet | ||||||
| Total Assets | 52.95B | 47.37B | 47.95B | 43.15B | 41.30B | 40.32B |
| Cash, Cash Equivalents and Short-Term Investments | 11.99B | 15.82B | 15.23B | 18.50B | 16.75B | 16.29B |
| Total Debt | 568.00M | 506.00M | 602.00M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 16.65B | 13.15B | 15.13B | 12.22B | 12.22B | 13.26B |
| Stockholders Equity | 36.30B | 34.22B | 32.82B | 30.93B | 29.08B | 27.06B |
Cash Flow | ||||||
| Free Cash Flow | 541.00M | 1.14B | -2.66B | 1.19B | 1.76B | 4.01B |
| Operating Cash Flow | 3.56B | 4.53B | 767.00M | 2.81B | 3.33B | 4.74B |
| Investing Cash Flow | -2.49B | -3.34B | -3.64B | -1.32B | -1.44B | -870.00M |
| Financing Cash Flow | -653.00M | -645.00M | -468.00M | 265.00M | -1.69B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥120.21B | 14.22 | ― | 1.08% | 0.48% | -4.27% | |
72 Outperform | ¥37.66B | 12.92 | ― | 2.23% | -0.25% | -41.09% | |
71 Outperform | ¥622.46B | 20.30 | 9.28% | 1.30% | 5.50% | 27.32% | |
68 Neutral | ¥25.61B | 15.65 | ― | 1.87% | 3.08% | -16.77% | |
66 Neutral | ¥24.61B | 10.14 | ― | 2.05% | 0.99% | 830.67% | |
63 Neutral | ¥249.65B | 17.96 | ― | 2.11% | 3.69% | -50.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |